Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > V James Cassella > Profile

V James Cassella

Affiliations

  • Chief Development Officer at Trevi Therapeutics Inc. (TRVI), 2025-02-20
  • Chief Development Officer at Concert Pharmaceuticals Inc. (CNCE), 2023-03-06
  • Former Evp, R&D And Cso at Alexza Pharmaceuticals Inc. (ALXA), 2015-05-05
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
CNCE $8.34 3,762 $31,375.08 173,061 2023-02-15 Filing
CNCE $8.35 10,106 $84,385.10 176,823 2023-01-30 Filing
CNCE $7.25 2,893 $20,974.25 186,929 2023-01-06 Filing
CNCE $3.09 3,762 $11,624.58 189,822 2022-02-14 Filing
CNCE $3.19 2,894 $9,231.86 83,084 2022-01-05 Filing